---
layout: post
title: 'USAN Watch: June 2013'
date: '2013-06-09T10:16:00.003+01:00'
author: John Overington
tags:
- INNS and USANS
modified_time: '2013-06-11T06:50:41.569+01:00'
thumbnail: http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-7779488250141476132
blogger_orig_url: http://chembl.blogspot.com/2013/06/usan-watch-june-2013.html
---

<div class="separator" style="clear: both; text-align: center;">
<a href="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png"><img border="0" src="http://3.bp.blogspot.com/-4fr-AOyvk_4/Trz_ix_nKaI/AAAAAAAABXk/qOg_xmhEf3I/s1600/inns+and+usans.png" /></a></div>
<span class="Apple-style-span" style="font-family: inherit;">The USANs for June 2013 have recently been published.</span><br />
<span class="Apple-style-span" style="font-family: inherit;"><br /></span>
<br />
<table border="1"><tbody>
<tr><td><b><span class="Apple-style-span" style="font-family: inherit;">USAN </span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Research Code </span></b></td><td><b>InChIKey (Parent)</b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Drug Class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Therapeutic class</span></b></td><td><b><span class="Apple-style-span" style="font-family: inherit;">Target</span></b></td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/beraprost.pdf">beraprost</a></td><td><div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
ML-1229</div>
</div>
</div>
</td><td><span style="background-color: white; line-height: 17px; text-align: left;"><span style="font-family: inherit;">CTPOHARTNNSRSR-OUKQBFOZSA-N</span></span></td><td>therapeutic</td><td>synthetic small molecule</td><td>PGI2R</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/esketamine-hydrochloride.pdf">esketamine&nbsp;hydrochloride</a></td><td><br /></td><td>YQEZLKZALYSWHR-ZDUSSCGKSA-N</td><td>therapeutic</td><td>synthetic small molecule</td><td>NMDAR</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/evolocumab.pdf">evolocumab</a></td><td>AMG-145</td><td>n/a</td><td>therapeutic</td><td>monoclonal antibody</td><td>PCSK9</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/idelalisib.pdf">idelalisib</a></td><td><br />
<div class="page" title="Page 1">
<div class="layoutArea">
<div class="column">
<span style="font-family: inherit;">GS-1101, CAL-101</span><span style="font-family: 'ArialMT'; font-size: 12.000000pt;">&nbsp;</span></div>
</div>
</div>
</td><td><span style="background-color: #fff9f0; color: #121212; line-height: 20px;"><span style="font-family: inherit;">IFSDAJWBUCMOAH-HNNXBMFYSA-N</span></span></td><td>therapeutic</td><td>synthetic small molecule</td><td>PI3K</td></tr>
<tr><td><a href="http://www.ama-assn.org/resources/doc/usan/rivipansel.pdf">rivipansel</a>, <a href="http://www.ama-assn.org/resources/doc/usan/rivipansel-hydrochloride.pdf">rivipansel hydrochloride</a></td><td><div class="page" title="Page 2">
<div class="layoutArea">
<div class="column">
<span style="font-size: 12pt;"><span style="font-family: inherit;">GMI-1070, PF-06460031&nbsp;</span></span></div>
</div>
</div>
</td><td>n/a</td><td>therapeutic</td><td>natural product-derived small molecule</td><td>selectin</td></tr>
</tbody></table>
